1 MCQs in Medicine for NEET PG
A 48-year-old woman with CKD Stage 3a (eGFR 52 mL/min/1.73m²) due to diabetic nephropathy is started on finerenone (a non-steroidal mineralocorticoid receptor antagonist) in addition to her existing lisinopril and amlodipine regimen. Which of the following is the PRIMARY mechanism by which finerenone reduces CKD progression?
Ready to test yourself?
Test your Medicine knowledge with AI-powered MCQs and detailed explanations — no signup required to try.
Sign up free and practice all 1 Finerenone — mechanism and CKD management MCQs with AI-powered explanations tailored to your performance.
Create Free Account